MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 1038915-75-1
Formula C19H20N4OMW 320.4Research-use catalog entryCOA/SDS by request

2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

CAS Number: 1038915-75-1

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Supply options

Availability by request

Availability
Available by request
Documents
COA/SDS available on request
Shipping
Shipping reviewed before dispatch

Public pricing is not shown for this CAS. Submit an RFQ to confirm availability, documentation, and shipping review.

Loading RDKit molecule structure...
InChIKey: PCHKPVIQAHNQLW-UHFFFAOYSA-NC19H20N4O | MW 320.4

Chemical Absolute Identifiers

CAS Number

1038915-75-1

PubChem CID

24958198

Molecular Formula

C19H20N4O

Molecular Weight

320.4 g/mol

Exact Mass

320.163711

InChIKey

PCHKPVIQAHNQLW-UHFFFAOYSA-N

IUPAC Name

2-(4-piperidin-3-ylphenyl)indazole-7-carboxamide

SMILES String

NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide (CAS 1038915-75-1) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C19H20N4O and molecular weight 320. 40 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Poly [ADP-ribose] polymerase 1 (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Poly [ADP-ribose] polymerase 1

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 8.49

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

Names & Synonyms

2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamideMK-4827 RacemateMK-4827 (Racemate)2-[4-(3-piperidyl)phenyl]indazole-7-carboxamide2-[4-(3-Piperidyl)phenyl]-2H-indazole-7-carboxamide
Show all synonyms
2-[4-(3-Piperidinyl)phenyl]-2h-indazole-7-carboxamide
External Identifiers
DSSTOX SUBSTANCE ID: DTXSID001365279CHEMBL ID: CHEMBL1098298CHEBI ID: CHEBI:177298HMDB ID: HMDB0244308
Literature & Patent References
DOI 10.1021/jm5018237Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.PMID 25761096Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination.DOI 10.1021/jm901188vDiscovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.PMID 19873981Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Niraparib tosylate monohydrateCAS 1613220-15-7
tert-Butyl (S)-3-(4-(7-carbamoyl-2H-indazol-2-yl)phenyl)piperidine-1-carboxylateCAS 1038916-11-8
4-(3-Piperidinyl)benzenamineCAS 19733-56-3
3-(4-Nitrophenyl)piperidineCAS 19733-55-2
1-Boc-3-(4-Aminophenyl)piperidineCAS 1171197-20-8

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1613220-15-7Niraparib tosylate monohydrateCAS 1038916-11-8tert-Butyl (S)-3-(4-(7-carbamoyl-2H-indazol-2-yl)phenyl)piperidine-1-carboxylateCAS 19733-56-34-(3-Piperidinyl)benzenamineCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 1038915-75-1

What are the key identifiers for 2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide (CAS 1038915-75-1)?

2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide is identified by CAS 1038915-75-1, with molecular formula C19H20N4O, molecular weight 320.4, InChIKey PCHKPVIQAHNQLW-UHFFFAOYSA-N.

Does CAS 1038915-75-1 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Poly [ADP-ribose] polymerase 1. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 1038915-75-1?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for 2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 1038915-75-1 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.